Melbourne Internal Medicine Associates
Melbourne, Florida 32901
0 studies enrolling now · 18 studies all time
What they study most
Alzheimer's Disease, Androgen-independent Prostate Cancer, Atrial Fibrillation, Atrial Flutter, Bradycardia, Brain Infarction, Breast Cancer, Cancer Cachexia, Cerebral Ischemia, Heart Disease, Hypertension, Ischemic Heart Disease
Studies at this site
- PhII ICb With/Without Erbitux in MBC Pts — Running, not enrolling
- TAC Versus TC for Adjuvant Breast Cancer — Completed
- A Long Term Study of the Safety of Tanezumab When Administered By Subcutaneous Injections — Stopped early
- Lead Registry for Optim Leads — Completed
- Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer — Completed
- Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation — Completed
- Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate Cancer — Completed
- Levels of Inflammatory Markers in the Treatment of Stroke-An SPS3 Ancillary Study — Completed
- Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC) — Completed
- Ixabepilone + Carboplatin Metastatic Breast Cancer — Completed
- Pre-op Rectal ChemoRad +/- Cetuximab — Completed
- Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial — Completed
- Evaluating E7389 in Patients With Hormone Refractory Prostate Cancer With Advanced and/or Metastatic Disease Stratified by Prior Chemotherapy — Completed
- A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease — Stopped early
- Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia. — Completed
- Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia — Completed
- Effectiveness of Pacemaker With Closed Loop Stimulation Compared to Pacemakers With and Without Standard Rate Response — Completed
- ASP-II: Ancrod Stroke Program: Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke — Stopped early